Skip to main content

Pharmacy

By April Dembosky, Kaiser Health News | 10:46 am | October 06, 2017
The bill, if signed by the California governor, would require drug companies to give notice to state agencies and health insurers if they plan to raise drug prices by 16 percent or more.
By Bernie Monegain | 08:48 am | October 04, 2017
The PCORI-funded study will compare the effectiveness of three approaches to reducing use of the painkillers.
By Michelle Andrews, Kaiser Health News | 02:10 pm | October 03, 2017
Mavyret's price tag of $26,400 for a course of treatment is significantly below that of other hepatitis C drugs whose sticker price ranges from about $55,000 to $95,000.
By Jay Hancock, Kaiser Health News | 11:16 am | October 02, 2017
The narrative from PhRMA's publicity campaign is only the rosiest, most self-serving version of pricing say critics.
By Jeff Lagasse | 03:17 pm | September 29, 2017
Since almost 75 percent of costs are attributable to antiretroviral drug treatment, reducing the price of those drugs could lead to even greater cost
By Beth Jones Sanborn | 10:10 am | September 26, 2017
Aegerion failed to inform providers of drug's risks outside prescribed usage, conspired to violate HIPAA, improperly distributed drug, DOJ says.
By Jeff Lagasse | 11:04 am | September 21, 2017
The Biosimilars Council has urged CMS to revisit their payment and coding policy and provide unique billing code and payment rate for these drugs.
By Jeff Lagasse | 02:56 pm | September 19, 2017
Most say payers should increase prices for those with poor health habits and offer affordable catastrophic health insurance plans.
By Beth Jones Sanborn | 02:44 pm | September 19, 2017
Proceeds used to buy a $3.6 million mansion formerly owned by Dwayne "the Rock" Johnson, a Ferrari, two Rolls Royces, other luxury autos, DOJ said.
By Mike Miliard | 10:50 am | September 18, 2017
By giving patients control over their data, the technology could enable better privacy protections, more efficiency and easier information exchange.